Neuropsychiatric illness: A case for impaired neuroplasticity and possible quantum processing derailment in microtubules

NeuroQuantology

Volumn 8, Issue 1, 2010, Pages 13-28

  Woolf, Nancy J ^a   Craddock, Travis J A ^b   Friesen, Douglas E ^b   Tuszynski, Jack A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Microtubules; Neuroplasticity; Neuropsychiatry; Psychopathology; Quantum processing

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOSKELETON PROTEIN; LITHIUM; NEUROLEPTIC AGENT; VALPROIC ACID;

ANIMAL MODEL; COGNITION; INFORMATION PROCESSING; MICROTUBULE; MOOD DISORDER; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; QUANTUM THEORY; REVIEW; SCHIZOPHRENIA;

EID: 77949945361     PISSN: None     EISSN: 13035150     Source Type: Journal    
DOI: None     Document Type: Review

References (125)

1. Alaerts M, Ceulemans S, Forero D. et al., Support for NRG1 as a susceptibility factor for schizophrenia in a northern Swedish isolated population. Arch Gen Psychiatry 2009; 66 (8):828-37.
2. Andrieux A, Salin PA, Vernet M. et al., The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev 2002; 16(18):2350-64.
3. Andrieux A, Salin P, Schweitzer A., et al., Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia. Biol Psychiatry 2006 1; 60(11):1224-30.
4. Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 2005;147:319-45.
5. Austin CP, Ky B, Ma L, Morris JA, Shughrue PJ. Expression of Disrupted-In-Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience 2004; 124(1):3-10.
6. Beck F and Eccles JC. Quantum aspects of consciousness and the role of consciousness. Proceedings of the National Academy of Science of the United States of America 1992; 89: 11357-11361.
7. Beck F. Synaptic Quantum Tunnelling in Brain Activity. NeuroQuantology; 2008; 6(2): 140-151.
8. Bégou M, Volle J, Bertrand JB., et al., The stop null mice model for schizophrenia displays [corrected] cognitive and social deficits partly alleviated by neuroleptics. Neuroscience 2008;11;157(1):29-39.
9. Belmont L, Mitchison T. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 1996:84(4):623- 31.
10. Benitez-King G, Ramirez-Rodriguez G, Ortiz L, Meza I. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Curr Drug Targets CNS Neurol Disord 2004 Dec;3(6):515-33.
11. Benitez-King G, Ramirez-Rodriguez G, Ortiz L. Altered Microtubule Associated Proteins in Schizophrenia. NeuroQuantology 2007; 5(1): 58-61.
12. Bennett A O MR. Consciousness and hallucinations in schizophrenia: the role of synapse regression. Aust N Z J Psychiatry 2008;42(11):915-31.
13. Bensimon G, Chermat R. Microtubule disruption and cognitive defects: effect of colchicine on learning behavior in rats. Pharmacol Biochem Behav 1991;38(1):141-5.
14. Bianchi M, Fone KF, Azmi N, Heidbreder CA, Hagan JJ, Marsden CA. Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci 2006;24(10):2894- 902.
15. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001;69(2):428-33.
16. Bohm D. A new theory of the relationship of mind to matter, Philosophical Psychology 1990; 3:271-286.
17. Bora E, Yücel M, Pantelis C. Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder? Acta Psychiatr Scand 2009; 120 (4):253-64.
18. Brandon NJ, Millar JK, Korth C, Sive H, Singh KK, Sawa A. Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci 2009; 14; 29 (41):12768-75.
19. Brass M, Haggard P. To do or not to do: the neural signature of self-control. J Neurosci 2007; 27(34):9141-5.
20. Brenner E, Sonnewald U, Schweitzer A, Andrieux A, Nehlig A. Hypoglutamatergic activity in the STOP knockout mouse: a potential model for chronic untreated schizophrenia. J Neurosci Res 2007;85(15):3487-93.
21. Brüne M. "Theory of mind" in schizophrenia: a review of the literature. Schizophr Bull 2005; 31(1):21-42.
22. Cannell GR, Bailey MJ, Dickinson RG. Inhibition of tubulin assembly and covalent binding to microtubular protein by valproic acid glucuronide in vitro. Life Sci 2002; 71(22):2633-43.
23. Cape EG, Jones BE. Differential modulation of high-frequency gamma-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J Neurosci 1998; 18(7):2653-66.
24. Cardno AG, Marshall EJ, Coid B., et al., Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999; 56(2):162-8.
25. Cash AD, Aliev G, Siedlak SL., et al., Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol 2003; 162(5):1623-7.
26. Castrén E. Is mood chemistry? Nat Rev Neurosci 2005; 6(3):241-6.
27. Cheng R, Juo SH, Loth JE., et al. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 2006; 11:252-260.
28. Cox MM, Tucker AM, Tang J, Talbot K, Richer DC, Yeh L, Arnold SE. Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav 2009; 8(4):390-7.
29. Craddock TJA, Tuszynski JA. A critical assessment of the information processing capabilities of neuronal microtubules using coherent excitations. J Biol Phys 2010; 36(1): 53-70.
30. Craddock TJA, Beauchemin C, Tuszynski JA. Information processing mechanisms in microtubules at physiological temperature: Model predictions for experimental tests. Biosystems 2009; 97(1):28-34.
31. Curmi P, Gavet O, Charbaut E., et al., Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct. Funct 1999: 24(5): 345-57.
32. de Lange FP, Spronk M, Willems RM, Toni I, Bekkering H. Complementary systems for understanding action intentions. Curr Biol 2008; 18(6):454-7.
33. Dean CE. Antipsychotic-associated neuronal changes in the brain: Toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 2006; 30(2):174-189.
34. Derksen MJ, Ward NL, Hartle KD, Ivanco TL. MAP2 and synaptophysin protein expression following motor learning suggests dynamic regulation and distinct alterations coinciding with synaptogenesis. Neurobiol Learn Mem 2007; 87(3):404-15.
35. Di Paolo, G, Pellier V, Catsicas M, Antonsson B, Catsicas S and Grenningloh G. The phosphoprotein stathmin is essential for nerve growth factor-stimulated differentiation. J Cell Biol 1996; 133(6):1383-90.
36. Di Patre PL, Oh JD, Simmons JM, Butcher LL. Intrafimbrial colchicine produces transient impairment of radial-arm maze performance correlated with morphologic abnormalities of septohippocampal neurons expressing cholinergic markers and nerve growth factor receptor. Brain Res 1990; 523(2):316-20.
37. Ehrlichman RS, Luminais SN, White SL., et al., Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res 2009; 1294:116-27.
38. Fischer A, Sananbenesi F, Schrick C, Spiess J, Radulovic J. Distinct roles of hippocampal de novo protein synthesis and actin rearrangement in extinction of contextual fear. J Neurosci 2004; 24(8):1962-6.
39. Fréchette M, Rennie K, Pappas BA. Developmental forebrain cholinergic lesion and environmental enrichment: behaviour, CA1 cytoarchitecture and neurogenesis. Brain Res 2009; 1252:172-82.
40. Frith CD. The Cognitive Neuropsychology of Schizophrenia. Hove, UK: Lawrence Erlbaum Associates, 1992.
41. Grenningloh G, Soehrman S, Bondallaz P, Ruchti E, Cadas H. Role of the microtubule destabilizing proteins SCG10 and stathmin in neuronal growth. J Neurobiol 2004; 58(1):60-9.
42. Gill M, Donohoe G, Corvin A. What have the genomics ever done for the psychoses? Psychol Med 2009; 12:1-12.
43. Globus G. Toward a quantum psychiatry: hallucination, thought insertion and DSM. NeuroQuantology 2010; 8(1): 1-13.
44. Gottmann K. Transsynaptic modulation of the synaptic vesicle cycle by cell-adhesion molecules. J Neurosci Res 2008; 86(2):223-32.
45. Hagan S, Hameroff SR, Tuszyński JA. Quantum computation in brain microtubules: decoherence and biological feasibility. Phys Rev E Stat Nonlin Soft Matter Phys 2002; 65(6 Pt 1):061901.
46. Hallett M. Volitional control of movement: the physiology of free will. Clin Neurophysiol. 2007; 118(6):1179-92.
47. Hameroff SR. Ultimate computing: Biomolecular consciousness and nanotechnology. Amsterdam: North Holland, 1987.
48. Hameroff S. Quantum computation in brain microtubules? The Penrose - Hameroff 'Orch OR' model of consciousness. Phil Trans R Soc Lond A 1998; 356: 1869-1896.
49. Hayden EP, Nurnberger JI Jr. Molecular genetics of bipolar disorder. Genes Brain Behav 2006; 5(1):85-95.
50. Heisenberg M. Is free will an illusion? Nature 2009; 459(7244):164-5.
51. Hennah W, Porteous D. The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes. PLoS One 2009; 4(3):e4906.
52. Hikida T, Jaaro-Peled H, Seshadri S., et al., Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 2007; 104(36):14501-6.
53. Hirose K, Löwe J, Alonso M, Cross RA, Amos LA. 3D electron microscopy of the interaction of kinesin with tubulin. Cell Struct Funct 1999; 24(5):277-84.
54. Howell B, Larsson N, Gullberg M and Cassimeris L. Dissociation of tubulin-sequestering and microtubules catastrophe-promoting activities of Oncoprotein 18/stathmin. Mol Biol Cell 1999; 10(1): 105-18.
55. Ikeda M, Aleksic B, Kirov G., et al., Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry 2010; 67(3):283-6.
56. Iwata M, Shirayama Y, Ishida H, Kawahara R. Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats. Neuroscience 2006; 141(3):1301-13.
57. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci 2009; 32(9):485-95.
58. Jaworski J, Kapitein LC, Gouveia SM,, et al., Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 2009; 61(1):85-100.
59. Jibu, M., Yasue, K. Advances in Consciousness Research Vol. 3, Quantum brain dynamics and consciousness: An introduction. John Benjamins Publishing Company, Philadelphia, 1995.
60. Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS. The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population. Neurosci Lett 2006; 407(2):101-6.
61. Kafka MS, Wirz-Justice A, Naber D, Moore RY, Benedito MA. Circadian rhythms in rat brain neurotransmitter receptors. Fed Proc 1983; 42(11):2796-801.
62. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of twelvemonth DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Archives of General Psychiatry 2005; 62(6):617-27.
63. Khuchua Z, Wozniak DF, Bardgett ME., et al., Deletion of the N-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory. Neuroscience 2003; 119(1);101-111.
64. Laeng P, Pitts RL, Lemire AL., et al., The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 2004; 91(1):238-51.
65. Law AJ, Hutchinson LJ, Burnet PW, Harrison PJ. Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex. J Neurosci Res 2004; 76(3):376-82.
66. Li D, Collier DA, He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006; 15(12):1995-2002.
67. MacDonald ML, Eaton ME, Dudman JT, Konradi C. Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiatry 2005; 57(9):1041-51.
68. Mandelkow EM, Lange G, Jagla A, Spann U, Mandelkow E. Dynamics of the microtubule oscillator: role of nucleotides and tubulin-MAP interactions. EMBO J 1988; 7(2):357-65.
69. Martin E, Ressler K, Binder E, Nemeroff C. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin N Am 2009; 32(3):549-75.
70. McCormick DA. Cholinergic and noradrenergic modulation of thalamocortical processing. Trends Neurosci 1989; 12(6):215-21.
71. McKemmish LK, Reimers JR, McKenzie RH, Mark AE, Hush NS. Penrose-Hameroff orchestrated objective-reduction proposal for human consciousness is not biologically feasible. Phys Rev E Stat Nonlin Soft Matter Phys 2009; 80(2 Pt 1):021912.
72. Mender D. Post-classical phase transitions and emergence in psychiatry: beyond George Engel's model of psychopathology. NeuroQuantology 2010; 8(1): 29-36.
73. Mendlewicz J. Disruption of the circadian timing systems: molecular mechanisms in mood disorders. CNS Drugs 2009; 23 Suppl 2:15-26.
74. Mershin A, Kolomenski AA, Schuessler HA, Nanopoulos DV. Tubulin dipole moment, dielectric constant and quantum behavior: computer simulations, experimental results and suggestions. Biosystems 2004; 77(1-3):73-85.
75. Mershin, A., Pavlopoulos, E., Fitch, O., Braden, B.C., Nanopoulos, D.V., Skoulakis, E.M.C. Learning and memory deficits upon TAU accumulation in Drosophilia mushroom body neurons, Learning & Memory 2004:11:277-87.
76. Mileusnic R, Lancashire CL, Rose SP. Recalling an aversive experience by day-old chicks is not dependent on somatic protein synthesis. Learn Mem 2005; 12(6):615-9.
77. Mitsuyama F, Niimi G, Kato K., et al., Redistribution of microtubules in dendrites of hippocampal CA1 neurons after tetanic stimulation during long-term potentiation. Ital J Anat Embryol. 2008; 113(1):17-27.
78. Mizukawa R, Iitsuka M, Hazama H, Ueda K, Tsushima J, Sugihara T, Kaneda W. Periodicity of episode occurrences in rapid cycling affective disorders. Biol Psychiatry 1992; 32(8):652-67.
79. Moncrieff J. A critique of the dopamine hypothesis of schizophrenia and psychosis. Harv Rev Psychiatry 2009; 17(3):214-25.
80. Nakata K, Lipska BK, Hyde TM., et al., DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc Natl Acad Sci USA 2009; 106(37):15873-8.
81. Nakayama T, Sawada T. Involvement of microtubule integrity in memory impairment caused by colchicine. Pharmacol Biochem Behav 2002; 71(1-2):119-38.
82. Nelson TJ, Backlund PS Jr, Alkon DL. Hippocampal protein-protein interactions in spatial memory. Hippocampus. 2004; 14(1):46-57.
83. Norrholm S, Ressler K. Genetics of anxiety and trauma-related disorders. Neurosci 2009; 164(1): 272-87.
84. O'Connell C, O'Malley A, Regan CM. Transient, learning-induced ultrastructural change in spatially-clustered dentate granule cells of the adult rat hippocampus. Neuroscience 1997; 76(1):55-62.
85. Oepen G, Baldessarini RJ, Salvatore P, Slater E. On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary. J Affect Disord 2004; 78(1):1-9.
86. Ohkawa N, Fujitani K, Tokunaga E, Furuya S, Inokuchi K. The microtubule destabilizer stathmin mediates the development of dendritic arbors in neuronal cells. J Cell Sci 2007; 120(8):1447-56.
87. Pabion M, Job D, Margolis RL. Sliding of STOP proteins on microtubules. Biochemistry 1984; 23(26):6642-8.
88. Penrose, R. Shadows of the mind. Oxford: Oxford University Press, 1994.
89. Priel A, Ramos AJ, Tuszynski JA, Cantiello HF. A biopolymer transistor: electrical amplification by microtubules. Biophys J 2006; 90(12):4639-43.
90. Priel A, Tuszynski JA, Woolf NJ. Neural cytoskeleton capabilities for learning and memory. J Biol Phys 2010; 36(1): 3-21.
91. Pokorný J, Hašek J, Jelínek F, Šaroch J and Palán B, Electromagnetic activity of yeast cells in the M phase, Electro- Magnetobiol 2001; 20(3):371-396.
92. Powell KJ, Hori SE, Leslie R, Andrieux A, Schellinck H, Thorne M, Robertson GS. Cognitive impairments in the STOP null mouse model of schizophrenia. Behav Neurosci 2007; 121(5):826-35.
93. Procopio M. Does god play dice with schizophrenia? A probabilistic model for the understanding of causation in mental illness. Med Hypotheses 2005; 64(4):872-7.
94. Rastad C, Ulfberg J, Lindberg P. Light room therapy effective in mild forms of seasonal affective disorder--a randomised controlled study. J Affect Disord 2008; 108(3):291-6.
95. Reimers JR, McKemmish LK, McKenzie RH, Mark AE and Hush NS. Weak, strong, and coherent regimes of Fröhlich condensation and their applications to terahertz medicine and quantum consciousness, PNAS 2009; 106(11): 4219-4224.
96. Ricciardi L and Umezawa H. Brain and Physics of Many-Body Problems, Kybernetik, 1967: 4(2):44-8.
97. Rujescu D, Ingason A, Cichon S., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009; 18(5):988-96.
98. Santarella, R.A., Skiniotis, G., Goldie, K. N., Tittmann, P., Gross, H., Mandelkow, E. M., Mandelkow, E., & Hoenger, A. Surface-decoration of microtubules by human tau. Journal of Molecular Biology, 2004 Jun;339(3):539-553.
99. Schulz P, Steimer T. Neurobiology of circadian systems. CNS Drugs 2009; 23( Suppl 2):3-13.
100. Segurado R, Detera-Wadleigh SD, Levinson DF, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 2003; 73(1):49-62.
101. Shumyatsky G, Tsvetkov E, Malleret G., et al. Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 2002: 111(6):905-18.
102. Singer W. Distributed processing and temporal codes in neuronal networks. Cogn Neurodyn 2009; 3(3):189-96.
103. Smith CU. The 'hard problem' and the quantum physicists. Part 2: Modern times. Brain Cogn 2009; 71(2):54-63.
104. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990; 336(8706):13-6.
105. Stapp H P. Quantum interactive dualism. Journal of Consciousness Studies 2005; 12(11):43-58.
106. Straub RE, Jiang Y, MacLean CJ., et al., Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71(2):337-48.
107. Steriade M. Acetylcholine systems and rhythmic activities during the waking--sleep cycle. Prog Brain Res 2004; 145:179-96.
108. Talbot K, Cho DS, Ong WY., et al., Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet 2006; 15(20):3041-54.
109. Tegmark M. Importance of quantum decoherence in brain processes. Phys Rev E 2000; 61(4 Pt B):4194-206.
110. Van Den Bogaert A, Schumacher J, Schulze TG., et al., The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003; 73(6):1438-43.
111. Van der Zee EA, Douma BR, Bohus B, Luiten PG. Passive avoidance training induces enhanced levels of immunoreactivity for muscarinic acetylcholine receptor and coexpressed PKC gamma and MAP-2 in rat cortical neurons. Cereb Cortex 1994; 4(4):376-90.
112. Vitiello G. Dissipation and memory capacity in the quantum brain model. Int J of Modern Physics B 1995; 9:973-989.
113. Vitiello G. Quantum Dissipation and Information: A route to consciousness modeling. NeuroQuantology 2003; 2(1): 266-279.
114. Walton JR. Brain lesions comprised of aluminum-rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer's disease. Neurotoxicology 2009 Jul 8.
115. Wegner DM. Précis of the illusion of conscious will. Behav Brain Sci 2004; 27(5):649-59; discussion 659-92.
116. Whitaker-Azmitia PM, Borella A, Raio N. Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia? Neuropsychopharmacology 1995; 12(3):269-72.
117. Woolf NJ. Cholinoceptive cells in rat cerebral cortex: somatodendritic immunoreactivity for muscarinic receptor and cytoskeletal proteins. J Chem Neuroanat 1993; 6(6):375-90.
118. Woodward TS, Mizrahi R, Menon M, Christensen BK. Correspondences between theory of mind, jumping to conclusions, neuropsychological measures and the symptoms of schizophrenia. Psychiatry Res 2009; 170: 119-123.
119. Woolf NJ, Young SL, Johnson GV, Fanselow MS. Pavlovian conditioning alters cortical microtubule-associated protein-2. Neuroreport 1994; 5(9):1045-8.
120. Woolf NJ, Zinnerman MD, Johnson GV. Hippocampal microtubule-associated protein-2 alterations with contextual memory. Brain Res 1999; 821(1):241-9.
121. Woolf NJ. Bionic microtubules: potential applications to multiple neurological and neuropsychiatric diseases. J Nanoneurosci 2009; 1:85-94.
122. Woolf, NJ, Priel A, and Tuszynski JA. Nanoneuroscience: Structural and Functional Roles of the Cytoskeleton in Health and Disease, Springer, Berlin, 2010.
123. Yamaguchi S, Fujii-Taira I, Murakami A., et al., Upregulation of microtubule-associated protein2 accompanying the filial imprinting of domestic chicks (Gallus gallus domesticus). Brain Res Bull 2008; 76(3):282-8.
124. Yang C, Wang G, Wang H, Liu Z, Wang X. Cytoskeletal alterations in rat hippocampus following chronic unpredictable mild stress and re-exposure to acute and chronic unpredictable mild stress. Behav Brain Res 2009; 205(2):518-24.
125. Zuo L, Luo X, Kranzler HR, Lu L., et al., Association study of DTNBP1 with schizophrenia in a US sample. Psychiatr Genet 2009; 19(6):292-304.